BioPharm Systems, a leading global IT consulting and managed services provider (MSP) specializing in Oracle's clinical trial, data, safety, and pharmacovigilance management systems, today announced that Sunovion Pharmaceuticals Inc. (Sunovion) has selected ASCEND for their clinical trial management system (CTMS). ASCEND is a pre-configured and enhanced version of Siebel Clinical, Oracle's CTMS. The system is configured to meet most organizations' CTMS requirements out-of-the-box, providing smaller organizations with what they need to get started and larger organizations with a robust base for their more complex needs.
For Sunovion, BioPharm Systems will implement ASCEND with minor custom configurations and integrate the system with the company's two preferred contract research organizations' (CROs') CTMS solutions. In addition, Sunovion has elected to host ASCEND in the cloud in BioPharm Systems' state-of-the-art data center.
"We are honored to have Sunovion as one of our newest hosted ASCEND clients," said Param Singh, vice president of clinical trial management solutions, BioPharm Systems. "Together, we have designed an implementation approach that involves rolling releases, which will allow Sunovion to finalize their process documentation, roll out training, and begin using their production system prior to all of the work streams being completed. This is cutting-edge and we are excited to get started."
Despite the complex nature of the project, the final work stream is scheduled to go live this year. Sunovion is planning more integrations with ASCEND over the next three years, including their clinical inventory management system (CIMS), electronic document management system (EDMS), Oracle Health Sciences Clinical Development Analytics (CDA) solution, as well as additional CROs.
BioPharm Systems is a Gold level member of Oracle PartnerNetwork (OPN) and an Oracle Accelerate solution provider. The company has achieved Specializations in Oracle Argus Safety Suite, Oracle Life Sciences Data Hub, and Oracle Accelerate for Midsize Companies.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Novel Agent Shows Superiority Over Placebo in Reducing Monthly Migraine Days
September 5th 2024Lu AG09222 shows promise as first-in-class medication that prevents neurogenic inflammation, vasodilation, and parasympathetic lacrimation, which are considered to be surrogate markers of migraine attacks.